Universal Ibogaine Inc.
Universal Ibogaine Inc. (IBO.V) Revenue
Annual & quarterly revenue history · segment & region breakdown
IBO.V · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsUniversal Ibogaine Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2022.
Revenue trend
2022 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-07-31 | $0.00B | +$0.00B | — |
| 2021-07-31 | $0.00B | +$0.00B | — |
| 2020-03-31 | $0.00B | +$0.00B | — |
| 2019-03-31 | $0.00B | +$0.00B | — |
| 2018-03-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Universal Ibogaine Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Universal Ibogaine Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Universal Ibogaine Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IBO.V revenue · 4 questionsIBO.V's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2022.
▸ Source: FMP · Universal Ibogaine Inc. SEC filings · GAAP · Universal Ibogaine Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026